Submitting OIG:
Report Description:
We identified actions that Washington has taken, using Federal funds for improving prescription drug monitoring programs (PDMPs), to achieve program goals toward improving safe prescribing practices and preventing prescription drug abuse and misuse. As of July 2018, Washington had completed some of the activities it proposed for the Centers for Disease Control and Prevention (CDC) grant to enhance and maximize its PDMP. Specifically, of the 11 activities proposed for the audit period (March 1, 2016, through August 31, 2017), 6 were completed, and the remaining 5 were partially completed.
Date Issued:
Monday, April 15, 2019
Agency Reviewed / Investigated:
Submitting OIG-Specific Report Number:
A-09-18-01001
Component, if applicable:
Centers for Disease Control and Prevention
Location(s):
Agency-Wide
Type of Report:
Audit
View Document:
Attachment | Size |
---|---|
91801001.pdf | 1.18 MB |
Additional Details Link: